Evidence map›Paper›PMID 29393449›Full record

ArticleMolecular medicine reports2018

Effect of cyclooxygenase‑2 inhibition on the development of post‑traumatic stress disorder in rats.

Mengyang Wang, Faliang Duan, Jinglei Wu, Qiang Min, Qiaochun Huang, Ming Luo, Zhuqiang He

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Emphasizing the Crosstalk Between Inflammatory and Neural Signaling in Post-traumatic Stress Disorder (PTSD).Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mengyang WangDepartment of Neurosurgery, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, P.R. China.
Faliang DuanDepartment of Neurosurgery, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, P.R. China.
Jinglei WuDepartment of Neurosurgery, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, P.R. China.
Qiang MinDepartment of Neurosurgery, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, P.R. China.
Qiaochun HuangDepartment of Neurosurgery, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, P.R. China.
Ming LuoDepartment of Neurosurgery, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, P.R. China.
Zhuqiang HeDepartment of Neurosurgery, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, P.R. China.
Wuhan No.1 Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post‑traumatic stress disorder (PTSD) is characterized by re‑experiencing of a traumatic event, avoidance of trauma‑associated stimulation, general changes in mood and cognition, and hyper arousal symptoms. Cyclooxygenase is involved in the production of prostaglandins and thromboxanes, and its inducible form cyclooxygenase‑2(COX‑2), an important mediator of cell injury in inflammation, is primarily expressed in leukocytes and brain cells. The present study investigated the expression of COX‑2 in the hippocampi of rats with PTSD and evaluated the effect of COX‑2 inhibition on PTSD. Adult male Wistar rats were randomly divided into three groups: Control (n=20), PTSD (n=20) and intervention group (PTSD+COX‑2 inhibitor treatment, n=20). The expression of COX‑2 was detected by immunohistochemistry, reverse transcription‑quantitative polymerase chain reaction and western blotting. Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling staining was used to observe the apoptosis of rat hippocampal neurons. Tumor necrosis factor α (TNF‑α), interleukin (IL)‑6 and prostaglandin E2 (PGE2) levels were analyzed by ELISA. Nitric oxide (NO) was detected using the Griess test. The behavioral and cognitive function of rats in the PTSD group was significantly decreased compared with the control group, while the behavioral and cognitive function of rats in the intervention group were improved. The COX‑2 mRNA and protein expression levels in hippocampi of rats in the PTSD group were higher than in the control and intervention group. The apoptosis of hippocampus in rats with PTSD was significantly increased compared with the control group and following treatment with COX‑2 inhibitor, apoptosis was decreased. In addition, compared with the control group and intervention group, the levels of TNF‑α, IL‑6, PGE2 and NO in hippocampi of rats were increased in the PTSD group. The present study indicated that COX‑2 may be involved in the pathogenesis of PTSD, and inhibition of its expression serves a neuroprotective role in hippocampi of PTSD rats.

Indexed as

AnimalsApoptosisBehavior, AnimalBiomarkersCyclooxygenase 2Cyclooxygenase 2 InhibitorsDinoprostoneDisease Models, AnimalGene ExpressionHippocampusImmunohistochemistryInterleukin-6MaleNeuronsRatsRNA, MessengerBiomarkersCyclooxygenase 2Cyclooxygenase 2 InhibitorsDinoprostoneInterleukin-6RNA, MessengerTumor Necrosis Factor-alphacyclooxygenase-2interleukin-6nitric oxidepost-traumatic stress disorderprostaglandin E2tumor necrosis factor α

Identifiers

PMID29393449
PMCPMC5865951
OpenAlexW2794300057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.